Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Br J Dermatol. 2008 Aug 5;159(5):1092–1102. doi: 10.1111/j.1365-2133.2008.08769.x

Fig 2.

Fig 2

Interleukin (IL)-17 and IL-22 receptors are expressed by keratinocytes and some dermal cells. Immunohistochemical analysis of IL-17R (a) and IL-22R1 (b) on normal human skin (n = 5) (inset, negative control). Scale bars = 100 µm. Confirmation of surface expression of IL-17R (c, filled area) and IL-22R1 (d, filled area) on keratinocyte single-cell suspensions compared with isotype control (dotted line) by flow cytometry. Double-label immunofluorescence shows that some CD11c+ dermal cells express IL-17R (e) but not IL-22R1 (f), while CD3+ cells in the dermis express neither receptor (g, h). Original magnification × 10.

HHS Vulnerability Disclosure